Pharmaceutical group Roche has announced a six per cent rise in first-quarter sales to SFr7.37 billion.
The company expects mid to high single digit growth to continue for the remainder of the year.
Sales in Roche's drug division rose five percent, when expressed in Swiss francs, while its diagnostics businesses yielded 9 percent.
Franz Humer, Roche's CEO, rejected speculation that the company was preparing a merger with drug giant Novartis.
swissinfo with agencies
In compliance with the JTI standards